We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





10-Minute COVID-19 Diagnostic Test Based on Nanoparticles Identifies IgG Antibodies and Costs Only Fifth of Market Average

By LabMedica International staff writers
Posted on 04 Feb 2021
A new COVID-19 test uses technology based on nanoparticles to detect antibodies to the novel coronavirus in 10 minutes and costs only a fifth of the market average.

The test developed by researchers at the University of São Paulo’s São Carlos Chemistry Institute (IQSC-USP; São Paulo, Brazil) and Biolinker (São Paulo, Brazil) works similarly to the rapid tests available now in pharmacies. More...
It analyzes a drop of blood, and two red LEDs light up if it detects the presence of immunoglobulin G (IgG) antibodies, which are produced in the acute phase of COVID-19 (10 days after the onset of symptoms on average). According to the researchers, the technology can easily be adapted to the novel SARS-CoV-2 variants, if necessary.

The test can be sold for less than USD 6 after it receives regulatory approval thanks to efforts by the researchers to optimize the quantity of raw materials and reagents in order to lower its production cost and develop a technology based on nanoparticles to facilitate IgG detection. The researchers combined a gold nanoparticle (which originates the red color) with a piece of the virus’s spike protein recognized by human antibodies. To develop the molecule used in the test device, the researchers worked in the laboratory to synthesize the docking tip of the spike protein, known as the receptor-binding domain (RBD), and used a recombinant DNA technology involving bacteria genetically modified to express the viral protein in vitro.

“The more antibodies there are in the blood, the brighter the red color. We believe this means the test can also be used to monitor the response to vaccination,” said Frank Crespilho, a professor at IQSC-USP and principal investigator for the study.

Related Links:
University of São Paulo
Biolinker



Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The new RABTA sets a high standard in laboratory diagnostics (Photo courtesy of Randox)

Pioneering Analyzer with Advanced Biochip Technology Sets New Standard in Lab Diagnostics

A state-of-the-art analyzer combines advanced technology with exceptional efficiency to meet the demanding needs of modern laboratories. Randox Toxicology (Antrim, Ireland) has launched its pioneering... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.